Clinical, histopathologic, and molecular profiles of PRKAR1A-inactivated melanocytic neoplasms - 10/03/21
Funding sources: None. |
|
Disclosure: Dr Williams, Authors Shah and Danziger, and Drs Montesion, Sokol, Pavlick, Miller, Ross, Elvin, and Tse are employees of Foundation Medicine, Inc, a wholly owned subsidiary of Roche Holdings, Inc and Roche Finance Ltd, and these employees have equity interest in an affiliate of these Roche entities. |
|
This work was presented as an oral abstract at the American Society of Dermatopathology Meeting, San Diego, CA, October 17, 2019. |
|
IRB approval status: Reviewed and approved by Western IRB (protocol no. 20152817). |
|
Reprints not available from the authors. |
Vol 84 - N° 4
P. 1069-1071 - avril 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?